A Repurposed Duo: Empagliflozin-Metformin Triggers a Metabolic Crisis in Cervical Cancer by Disrupting the Acyl-CoA/CoA Ratio via Dual Inhibition of PPAT and CPT1A. J. Can. Res. Updates [Internet]. 2025 Dec. 31 [cited 2026 May 24];14:247-65. Available from: https://mail.neoplasiaresearch.com/index.php/jcru/article/view/922